drugset / Trial / NCT00166543
Three Doses of TAS-108 to Treat Recurrent or Recurrent Inoperable Breast Cancer
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is being done to find out how safe TAS-108 is and how well TAS-108 works on recurrent or recurrent inoperable breast cancer.
Timeline
- Start
- 2004-05
- Primary completion
- 2008-01
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TAS-108 | Small molecule | 40 mg | Oral |
| Subject | TAS-108 | Small molecule | 80 mg | Oral |
| Subject | TAS-108 | Small molecule | 120 mg | Oral |